are compounding pharmacies allowed to make semaglutide Compounded' weight-loss drugs a growing problem for state regulators • Stateline Dr. Celine Gounder explains why

Taking semaglutide long-term may not be a fit for individuals with certain health conditions or those who experience severe side effects

Although central activity is likely to contribute to visceral hypersensitivity, peripheral factors, including immune, paracrine and endocrine molecules, are also likely to play a role in the sensitisation of gut-to-brain signalling in IBS

Transl Neurodegener

At our online weight loss clinic, we offer different types of weight loss treatments to help you with your weight loss journey

Wegovy (semaglutide 2.4 mg) is a once-weekly injectable medicine licensed in the UK for weight management in adults with obesity or overweight with at least one related health condition

doi:10.1111/ejn.14096 2022 The Author(s)